Defense Health Program Department of Defense Multiple Sclerosis Research Program Anticipated Funding Opportunities for Fiscal Year 2021 (FY21) - September 7, 2021 deadlines

How to Apply: 

The FY21 Defense Appropriations Act provides funding to the Department of Defense Multiple Sclerosis Research Program (MSRP) to support innovative and impactful research that addresses fundamental issues and gaps in Multiple Sclerosis (MS). As directed by the Office of the Assistant Secretary of Defense for Health Affairs, the Defense Health Agency J9, Research and Development Directorate manages the Defense Health Program (DHP) Research, Development, Test, and Evaluation (RDT&E) appropriation. The managing agent for the anticipated program announcements/funding opportunities is the Congressionally Directed Medical Research Programs (CDMRP) at the U.S. Army Medical Research and Development Command (USAMRDC).

 

The FY21 MSRP program announcements and General Application Instructions for the following award mechanisms are posted on the Grants.gov website.    

 

Applications submitted to the FY21 MSRP must address at least one of the Focus Areas relevant to the award mechanism as described in the table below.

 

https://cdmrp.army.mil/funding/msrp

 

Early Investigator Research Award – Letter of Intent due September 7, 2021

The Principal Investigator must:

o   Possess a doctoral degree (or equivalent) from an accredited organization; and

o   Have 4 years or less of postdoctoral research experience at the time of application submission (excluding clinical residency or clinical fellowship training); and

o   Commit at least 50% of the effort toward the proposed project.

  • Supports MS-focused research opportunities for individuals in the early stages of their careers
  • Designated mentor who is an experienced MS researcher
  • Clinical trials not allowed
  • Must address at least one of the following Focus Areas:
    • Central nervous system regenerative potential in demyelinating conditions
    • Correlates of disease activity and progression in MS
    • Biology and measurement of MS symptoms
    • Factors contributing to MS etiology, prodrome, onset, and disease course

o   Interactions between MS and COVID-19

o   Only postdoctoral fellows are eligible for this award. Faculty members and all other non-postdoctoral positions are not eligible to apply.

  • Maximum funding of $200,000 for direct costs (plus indirect costs)
  • Maximum period of performance is years

 

External Deadline: 
Tuesday, September 7, 2021
Funding Source: 
External
Funding Level: 
Research